The Pill Book 10th Edition: New and Revised
Description:
For two decades, millions of consumers have trusted The Pill Book to provide official, FDA-approved drug information plus guidelines from leading pharmacists. Each drug is profiled in a concise, readable, and easy-to-understand entry, making The Pill Book the perfect reference when you have questions about the medications your doctor prescribes.
The consumer’s guide to pills—more than 35 important new drugs approved for sale in 2002 and dozens of new brand names in this completely revised 10th edition
The most up-to-date information about the 1,500 most commonly prescribed drugs in the United States
:• Generic and brand-name listings that can help you save money
• What the drug is for, and how it works
• Usual dosages, and what to do if a dose is skipped
• Side effects and possible adverse reactions,
highlighted for quick reference
• Interactions with other drugs and food
• Overdose and addiction potential
• Alcohol-free and sugar-free medications
• Information for seniors, pregnant and breast-feeding women,
children, and others with special needs
• Cautions and warnings, and when to call your doctor
PLUS
32 pages of actual-size color photographs of prescription pills.
Best prices to buy, sell, or rent ISBN 9780553381603
Frequently Asked Questions about The Pill Book 10th Edition: New and Revised
The price for the book starts from $7.79 on Amazon and is available from 18 sellers at the moment.
If you’re interested in selling back the The Pill Book 10th Edition: New and Revised book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the The Pill Book 10th Edition: New and Revised book, the best buyback offer comes from and is $ for the book in good condition.
The The Pill Book 10th Edition: New and Revised book is in very low demand now as the rank for the book is 5,821,749 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.